Crossmark Global Holdings Inc. Has $24.83 Million Stock Position in Merck & Co., Inc. $MRK

Crossmark Global Holdings Inc. has reduced its stake in Merck & Co., Inc. by 7.6% in the fourth quarter, now holding 235,906 shares valued at approximately $24.83 million. Despite this trimming, Wall Street analysts maintain a “Moderate Buy” consensus rating for Merck with an average price target of $128.18, following positive quarterly results and new developments in its pipeline. However, the company faces potential litigation risk concerning its Gardasil vaccine, which could impact future sentiment.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin